按照ADA-糖尿病诊断新标准对一组危险人群1139例的普查(RIAD-研究)

来源 :The Chinese-German Journal of Clinical Oncology | 被引量 : 0次 | 上传用户:ppasu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
1997年美国糖尿病协会(ADA)提出Ⅱ型糖尿病诊断新标准:空腹血糖(血浆葡萄糖)的正常上限值由140mg/dl降为126mg/dl,空腹血糖介于110~124mg/dl认为空腹血糖失常。作者按照ADA新标准,对德国居民中一组糖尿病危险人群进行普查,观察新发现的Ⅱ型糖尿病、糖耐量减低和空腹血糖失常三者的流行病学(RIAD-研究,Riskfactors in IGTfor aherosclerosis and diabetet)。普查对象和方法:对象为一组糖尿病危险人群1139例,年龄40~70岁,均为糖尿病患者的亲族和/或身患高血压、高血脂症、肥胖症等疾病者,但除外明显的糖尿病。所有对象均进行一次口服葡萄糖(75g)耐量试验(cGTT),血糖水平用作不同糖耐量的分类。结果:按照ADA-诊断新标准(ADA-WHO 1998),上述危险人群中的糖尿病发病率上升为15.1%,按原习用标准为11%;葡萄糖耐量减低者的发病率为26.2%(按原习用标准为28.8%);空腹血糖失常(血糖介于110~126mg/dl)者为27.1%,此中9.2%患者的cGTT2h血糖值相当于糖尿病诊断标准(可诊断为糖尿病)。男性40~49岁组中有14%为原来未发现的Ⅱ型糖尿病,约一倍于女性40~49岁组(6%)。此外,高血压、高血脂症和肥胖症等合并存在的疾病,在糖尿病和糖耐量减低者中,显著高于在血糖正常者中。结论:在这一危险人群中,按习用诊断标准未被 1997 American Diabetes Association (ADA) proposed a new diagnostic criteria for type 2 diabetes: normal upper limit of fasting plasma glucose (plasma glucose) decreased from 140mg / dl to 126mg / dl, fasting blood glucose between 110 ~ 124mg / dl that fasting blood glucose disorders . The authors conducted a census of a group of at-risk diabetic populations in German residents according to the new ADA criteria and observed the epidemiology of newly discovered type 2 diabetes, impaired glucose tolerance and impaired fasting glucose (RIAD-Risk, Risk Factors in IGT for aherosclerosis and diabetet ). Census objects and methods: The object of a group of 1139 people at risk for diabetes, aged 40 to 70 years old, are diabetic and / or suffering from hypertension, hyperlipidemia, obesity and other diseases, except for obvious diabetes . All subjects underwent an oral glucose (75 g) tolerance test (cGTT) and blood glucose levels were used as a classification of different glucose tolerances. Results: According to the new ADA-WHO criteria (ADA-WHO 1998), the prevalence of diabetes mellitus in these at-risk groups increased to 15.1% based on the original criteria of 11% and the incidence of impaired glucose tolerance was 26.2% Standard 28.8%); fasting blood glucose disorders (blood glucose between 110 ~ 126mg / dl) was 27.1%, of which 9.2% of patients with cGTT2h blood glucose equivalent to the diagnostic criteria for diabetes (can be diagnosed with diabetes). Fourteen percent of men in the 40-49 age group were previously untreated type 2 diabetes, which was about twice as many as women in the 40-49 age group (6%). In addition, co-existing diseases such as hypertension, hyperlipidemia and obesity are significantly higher in those with diabetes and impaired glucose tolerance than in those with normal blood glucose. CONCLUSIONS: According to the prevalence of diagnostic criteria, this group of people at risk is not
其他文献
离休后,闲暇无事,随意翻阅史料,偶得“兰州水烟”诗四首,因而使我回想起建国之初,五十年代,我在盛产兰州水烟的苑川河畔的金家崖、夏官营税务所工作,虽然时隔40余年,但对烟
重病肌无力(MG)是T细胞依赖性,自身抗体介导以横纹肌无力和易疲劳为特征的自身免疫性疾病[1]。自身抗体对突触后膜烟碱型乙酰胆碱受体(nAchR)的自身免疫攻击引起AchR数目的减少,而导致肌无力的发生
患者大,38岁,因月经量多伴进行性痛经,以子宫平滑肌瘤,右侧卵巢陈旧性出血性囊肿,慢性宫颈炎等入院。查血 WBC 4.9 ×10~9/L,PLT 156×10~9/L,Hb 90g/L。于入院后第 4天在硬
目的 探讨重症肌无力 (MG)患者中枢神经系统 (CNS)受损时白细胞介素 - 6 (IL - 6 )水平的变化及其意义 ,进一步阐明MG之CNS受损的免疫机制。方法 将MG患者血中提取的乙酰胆
各位领导,各位代表:浙江省图书馆学会第六次会员代表大会今天开幕了,我受省文化厅党组书记、厅长杨建新同志的委托,代表省文化厅向大会表示热烈的祝贺,并预祝大会圆满成功。
刺五加在临床上可用于治疗多种疾病[1],为了解刺五加在糖尿病肾病(DN)的抗氧化作用,笔者观察了刺五加注射液治疗DN前后过氧化脂质(LPO)、超氧化物歧化酶(SOD)变化,现报道如下。1 资料与方法1.1 临床资
2000年11月,江西考古工作者对鹰潭角山遗址进行了第三次发掘,并取得重大突破。           一 江西鹰潭南为武夷山脉,北为怀玉山脉,两山脉南北麓相会处有信江自东向西流过,注
诺氟沙星是第三代喹诺酮类抗菌药物。因具有抗菌谱广、抗菌力强、与其它抗菌类药物之间无明显交叉耐药性等优点而被广泛地运用于临床,但近年来也发现一些不良反应。现将该药
1型糖尿病是一种自身免疫性疾病,是通过复杂的遗传和环境因素相互作用而引起的。象许多自身免疫性疾病一样,1型糖尿病以免疫调节紊乱为特征,这种紊乱先于显性临床发病。人及
曾几何时,当中国经济在低水平徘徊,国内市场上出现严重的供给与需求矛盾,政府致力于启动、刺激消费,一种新的消费形式便悄然兴起,从1999年便开始出现了强劲的增长势头,并为